ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Entresto 15 mg/16 mg, filmüberzogenes Granulat - 60
69255002 Novartis Pharma Schweiz AG
Entresto 15 mg/16 mg, filmüberzogenes Granulat21.08.2024
  21.08.2024
Valsartan and Sacubitril (C09DX04) 
WHO-DDD20.08.2029
60
02.07.20. 
B  
No 
IPCI
   
k.A. 
  
7680692550026Synthetika
  
Composition
Granulat: sacubitrilum 15.18 mg et valsartanum 16.07 mg ut complexus sacubitrili et valsartani natrii hydricus, cellulosum microcristallinum, hydroxypropylcellulosum, magnesii stearas, silica colloidalis anhydrica, talcum, Überzug: copolymerum methacrylatis butylati basicum, talcum, acidum stearicum, natrii laurilsulfas, ad granulatum pro, natrium 2.6 mg.
Packungsbestandteile
filmüberzogenes Granulat
 
Active AgentDoseadditional_information
Sacubitrilum15.18 mgGranulat
Valsartan16.07 mg 
 
Inactive agentsDoseadditional_information
Acidum Stearicum  
Ad Granulatum  
Cellulosum Microcristallinum  
Copolymerum Methacrylatis Butylati Basicum Überzug
Hydroxypropylcellulosum  
Magnesii Stearas  
Natrii Laurilsulfas  
Sodium2.6 mg 
Silica Colloidalis Anhydrica  
Talcum  
Valsartani Natrii Hydricus  
Source
Data was imported : 09.01.2026 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home